abstract |
The present invention relates to novel quinazoline derivatives, solvates, stereoisomers, or pharmaceutically acceptable salts thereof having antitumor activity, and a pharmaceutical composition comprising the same as an active ingredient. The novel quinazoline derivatives of the present invention may exhibit selective and effective activity against cancers having EGFR and/or HER2 mutations. |